Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Midwife-led Childbirth Review and Psychological Outcomes in New Parents (CROWN)

25. Juni 2026 aktualisiert von: Michal Zikán, Charles University, Czech Republic

Effects of a Midwife-led Childbirth Review on Psychological Outcomes in New Parents

The aim of this clinical trial is to support psychological well-being and facilitate adjustment to parenthood among postpartum mothers and fathers through a midwife-led childbirth review (MLCR). MLCR is a structured 45-60-minute postpartum intervention focused on processing and integration of the individual's childbirth experience, involving active listening, emotional support, and provision of information. In this study, the investigators will employ the MLCR intervention developed by Gamble and Creedy (2009) for women with traumatic birth experiences, adapted for use in the general population of new parents, including both mothers and fathers/partners. This study will compare the effectiveness of three MLCR models - MLCR provided within the first postpartum week, MLCR provided at 6-8 weeks postpartum, and MLCR provided at both time points - with standard postpartum care and with each other.

Studienübersicht

Detaillierte Beschreibung

Childbirth is a profound experience that may have long-term effects on maternal mental health and psychosocial functioning. While a positive childbirth experience may enhance psychological well-being, a negative childbirth experience has been associated with an increased risk of postpartum mental health difficulties, including post-traumatic stress disorder and postpartum depression.

In maternity care settings, a frequently used intervention aimed at processing childbirth experience is postpartum debriefing, which provides mothers with an opportunity to discuss their birth experience with a healthcare professional, most commonly a midwife. Postpartum debriefing provided by midwives has been integrated into maternity care in some countries and is offered as a targeted intervention to women after traumatic childbirth to reduce postpartum psychological morbidity. In some settings, however, postpartum debriefing is offered universally to all postpartum women; this is in line with qualitative studies showing that most women appreciate midwives initiating discussions about childbirth, listening to their experiences with empathy and support, and providing them with relevant information.

Reviewing childbirth experience with a supportive healthcare professional may help women facilitate understanding and integration of this emotionally and physically demanding event while gaining a sense of closure. Consequently, postpartum debriefing with a midwife may not only reduce the risk of psychiatric problems in women with traumatic childbirth experiences but may also be beneficial for the general population of postpartum women as a supportive intervention promoting psychological adjustment after childbirth. Following Sheen and Slade (2015), we refer to this type of supportive intervention as "childbirth review" to distinguish it from psychological debriefing provided following an adverse event.

Although postpartum debriefing is widely used in maternity care settings and recommended by policymakers, evidence regarding its effectiveness in improving postpartum mental health remains inconsistent and of limited quality. In addition, studies focusing on outcomes such as postpartum anxiety, parenting competence, sleep, social relationships, or future reproductive choices are lacking. Moreover, previous research has focused primarily on postpartum mothers, while largely omitting fathers present at childbirth.

This study aims to address these gaps by evaluating the effectiveness of midwife-led childbirth review (MLCR) offered to all postpartum women, as well as their partners present at childbirth, in order to improve postpartum psychological outcomes. MLCR employed in this study is based on the counselling model developed by Gamble and Creedy (2009) to support women with traumatic births and adapted for the general population of parents in the postpartum period. In this study, MLCR is conceptualized as a supportive discussion about childbirth experience intended to facilitate its understanding and processing in new parents.

MLCR will be delivered by midwives in a structured 45-60-minute session and will include review of the childbirth experience, active listening, emotional support, clarification of childbirth-related events and procedures when needed, and provision of information related to the birth. Mothers and fathers/partners will receive MLCR separately. To ensure intervention consistency, all participating midwives will complete standardized training and receive a detailed intervention manual before study initiation. Supervision procedures and an intervention fidelity plan will be implemented throughout the study. Standard postpartum care will not include the structured MLCR procedure or predefined intervention elements.

Participants (pregnant women and their partners) will be recruited during the third trimester of pregnancy from Bulovka University Hospital in Prague and University Hospital Brno. Data will be collected during late pregnancy, within the first postpartum week, at 6-8 weeks postpartum, and at 6 months postpartum.

Following childbirth and confirmation of study eligibility, women will be randomized to one of four groups: (1) MLCR within the first postpartum week, (2) MLCR at 6-8 weeks postpartum, (3) MLCR at both time points, or (4) standard postpartum care. Randomization will be stratified by key obstetric and psychological characteristics (parity, mode of birth, childbirth experience, psychiatric history). Fathers/partners will be assigned to the same study group as the mother.

The primary outcomes are maternal symptoms of postpartum depression and perinatal anxiety. The primary hypothesis is that mothers receiving any form of MLCR will report lower levels of symptoms of postpartum depression and perinatal anxiety at 6 months postpartum than mothers receiving standard postpartum care. In addition, repeated MLCR will be more effective than single-session MLCR, and early-only and later-only MLCR will differ in their effects on maternal postpartum depression and perinatal anxiety symptoms at 6 months postpartum. At 6-8 weeks postpartum, mothers who received MLCR within the first postpartum week are expected to report lower levels of depressive and anxiety symptoms than mothers who had not yet received MLCR. We will also examine whether baseline depressive and anxiety symptoms during pregnancy moderate the effects of MLCR on postpartum psychological outcomes.

Secondary outcomes for mothers include symptoms of general anxiety, parenting sense of competence, mother-infant bonding, sleep, relationship satisfaction, perceived stress, birth experience, childbirth-related post-traumatic stress symptoms, observed mother-infant interaction quality, and future reproductive choices. Hypotheses tested for secondary outcomes in mothers correspond to those for the primary outcomes.

Data from fathers will be analyzed separately as secondary analyses, as we expect a substantially smaller sample size for fathers. Outcomes/hypotheses related to paternal data will parallel those for maternal data.

Studientyp

Interventionell

Einschreibung (Geschätzt)

1300

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

      • Brno, Tschechien, 60200
        • University Hospital Brno
        • Kontakt:
        • Kontakt:
        • Hauptermittler:
          • Andrea Mensikova, PhD, MHM
        • Unterermittler:
          • Miloslava Kamenikova, Dr
      • Prague, Tschechien, 18100
        • Bulovka University Hospital
        • Kontakt:
        • Kontakt:
        • Hauptermittler:
          • Michal Zikan, MD, PhD
        • Unterermittler:
          • Milada Baresova

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Beschreibung

Inclusion Criteria:

Pregnant women: Age ≥ 18 years; Singleton pregnancy; Fluency in Czech; Women can enter the study without a partner; Live birth after enrollment. Partners: Partner of an enrolled woman; Age ≥ 18 years; Planning on being present at childbirth; Fluency in Czech

Exclusion Criteria:

Pregnant women: Age < 18 years; Multi-fetal pregnancy; Not being able to read and speak fluent Czech; A severe medical condition including significant pregnancy complications preventing participation in the intervention or assessments; Stillbirth or neonatal death; Infant admitted to intensive care for a prolonged or life-threatening condition; Acute psychiatric condition (suicidality, psychosis, manic episode, substance abuse). Partners: Age < 18 years; Not being able to read and speak fluent Czech; Not planning on being present at childbirth / after recruitment: not present at childbirth; A severe medical condition preventing participation in the intervention or assessments; Stillbirth or neonatal death; Infant admitted to intensive care for a prolonged or life-threatening condition; Acute psychiatric condition (suicidality, psychosis, manic episode, substance abuse)

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Verhütung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Experimental group A
MLCR within the first postpartum week.
MLCR is a structured 45-60 min session that includes review of childbirth experience, active listening, emotional support, clarification of childbirth-related events and procedures when needed, and provision of information related to the birth.
Experimental: Experimental group B
MLCR at 6-8 weeks postpartum
MLCR is a structured 45-60 min session that includes review of childbirth experience, active listening, emotional support, clarification of childbirth-related events and procedures when needed, and provision of information related to the birth.
Experimental: Experimental group C
MLCR both within the first postpartum week and at 6-8 weeks postpartum
MLCR is a structured 45-60 min session that includes review of childbirth experience, active listening, emotional support, clarification of childbirth-related events and procedures when needed, and provision of information related to the birth.
Kein Eingriff: Control group (group D)
Standard postpartum care. This care may include routine clinical communication with healthcare professionals but will not include the structured 45-60 min MLCR intervention or predefined MLCR elements.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Depressive symptoms measured via the Edinburgh Postnatal Depression Scale (EPDS)
Zeitfenster: Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
EPDS is a 10-item self-report questionnaire to screen for postpartum depression but has also been validated for the use in pregnant women. The score may range from 0 to 30, with higher scores indicating higher levels of depressive symptoms.
Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
Perinatal anxiety symptoms measured via the Perinatal Anxiety Screening Scale (PASS)
Zeitfenster: Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
PASS is a 31-item self-report questionnaire developed to screen for a broad range of anxiety symptoms during pregnancy and the postpartum period. It consists of four subscales: Acute Anxiety and Adjustment; General Worry and Specific Fears; Perfectionism, Control and Trauma; Social Anxiety. The score may range from 0 to 93, with higher scores indicating more severe anxiety.
Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Anxiety symptoms measured via the State-Trait Anxiety Inventory - state - short 5-item version (STAIS-5)
Zeitfenster: Baseline (third trimester of pregnancy), within the first postpartum week, 6-8 weeks postpartum, 6 months postpartum
STAIS-5 is a 5-item self-report questionnaire assessing state anxiety, i.e. how the person felt at the moment. The score may range from 5 to 20, with higher scores indicating higher levels of state anxiety.
Baseline (third trimester of pregnancy), within the first postpartum week, 6-8 weeks postpartum, 6 months postpartum
Anxiety symptoms measured via the Generalized Anxiety Disorder Scale (GAD-7)
Zeitfenster: Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
GAD-7 is a 7-item scale measuring worry and anxiety symptoms. The score may range from 0 to 21, with higher scores indicating greater anxiety severity.
Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
Maternal parenting self-esteem measured via the Maternal Self-report Inventory (MSRI)
Zeitfenster: Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
MSRI is a 26-item self-report questionnaire measuring maternal parenting self-esteem. The score may range from 26 to 130, with higher scores indicating higher maternal self-esteem. The version for pregnancy contains 12 items.
Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
Parenting self-esteem measured via the Parenting Sense of Competence Scale (PSOC)
Zeitfenster: 6 months postpartum
The PSOC is a 17-item self-report questionnaire assessing parenting self-esteem. It consists of two subscales: Satisfaction and Efficacy. The total score may range from 17 to 102, with higher scores indicating higher parenting self-esteem.
6 months postpartum
Maternal bonding to the infant measured via the Maternal Postnatal Attachment Scale (MPAS)
Zeitfenster: 6-8 weeks postpartum, 6 months postpartum
MPAS is a 19-item self-report questionnaire measuring maternal emotional tie to her child. MPAS has three subscales: Quality of attachment, Absence of hostility, Pleasure in interaction. The total score may range from 19 to 95, with higher scores indicating better bonding.
6-8 weeks postpartum, 6 months postpartum
Paternal bonding to the infant measured via the Paternal Postnatal Attachment Scale (PPAS)
Zeitfenster: 6-8 weeks postpartum, 6 months postpartum
PPAS is a 19-item self-report questionnaire measuring paternal emotional tie to his child. PPAS has three subscales: Patience and tolerance, Pleasure in interaction, Affection and pride. The total score may range from 19 to 95, with higher scores indicating greater bonding.
6-8 weeks postpartum, 6 months postpartum
Sleep quality measured via the Pittsburgh Sleep Quality Index
Zeitfenster: Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
PSQI is a 19-item self-reported questionnaire that assesses sleep quality and disturbances. It consists of 7 component scores: sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleeping medication, and daytime dysfunction. The total score may range from 0 to 21, with higher scores indicating a poorer sleep quality.
Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
Relationship satisfaction measured via the Relationship Assessment Scale (RAS)
Zeitfenster: Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
RAS is a 7-item questionnaire measuring global relationship satisfaction. The total score may range from 7 to 35, with higher scores indicating higher satisfaction.
Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
Perceived stress measured via the Perceived Stress Scale (PSS)
Zeitfenster: Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
PSS is a 10-item measure detecting how often respondents perceived their lives as stressful, unpredictable, uncontrollable, and overwhelming in the last two weeks. The total score may range from 0 to 40, with higher scores indicating higher levels of perceived stress.
Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
Birth experience measured via the Birth Experiences Questionnaire (BEQ)
Zeitfenster: Within the first postpartum week, 6-8 weeks postpartum, 6 months postpartum
BEQ is a 10-item measure designed to assess parents' subjective birth experience, including perceptions of stress, fear, pain, control, partner support, and overall evaluation of childbirth. The total score may range from 10 to 70, with higher scores indicating more negative birth experience.
Within the first postpartum week, 6-8 weeks postpartum, 6 months postpartum
Childbirth-related post-traumatic stress symptoms measured via the City Birth Trauma Scale (CityBiTS)
Zeitfenster: 6-8 weeks postpartum, 6 months postpartum
CityBiTS is a 29-item self-report questionnaire assessing post-traumatic stress symptoms following childbirth based on the DSM-5 criteria for PTSD. The total score may range from 0 to 60, with higher scores indicating higher levels of post-traumatic stress symptoms.
6-8 weeks postpartum, 6 months postpartum
Mother-infant interaction quality observed during a free play, assessed via coding scheme developed by Gartstein et al. (2008, 2018)
Zeitfenster: 6 months postpartum
The coding scheme developed by Gartstein et al. (2008, 2018) provides ratings for the following domains: maternal sensitivity/responsiveness; synchrony/reciprocity of the dyad; tempo of the interactions; intensity of exchange; emotional tone; and child versus parent directedness. Each domain is rated on a 7-point Likert scale (from 1 to 7) with higher scores reflecting higher levels of the respective attribute. Two composite scores can be created: Engagement and Stimulation.
6 months postpartum
Future reproductive choices assessed via the questionnaire items developed specifically for the purposes of this study.
Zeitfenster: 6 months postpartum
Questions focusing on preferred mode of delivery in future childbirth, intention to have another child, and intention to postpone future pregnancy.
6 months postpartum

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Studienleiter: Lea Takacs, PhD, Masaryk University
  • Hauptermittler: Michal Zikan, MD, PhD, Bulovka University Hospital

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

6. Juli 2026

Primärer Abschluss (Geschätzt)

15. März 2028

Studienabschluss (Geschätzt)

15. Juli 2028

Studienanmeldedaten

Zuerst eingereicht

25. Juni 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

25. Juni 2026

Zuerst gepostet (Tatsächlich)

1. Juli 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

1. Juli 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

25. Juni 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

A deidentified data will be shared at the request of qualified investigators for the purpose of further research.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren